TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells

[1]  R. Curi,et al.  Soy lecithin supplementation alters macrophage phagocytosis and lymphocyte response to concanavalin A: a study in alloxan‐induced diabetic rats , 2008, Cell biochemistry and function.

[2]  M. Neurath,et al.  NF‐κB in inflammatory bowel disease , 2008, Journal of internal medicine.

[3]  W. Stremmel,et al.  Increased basolateral sorting of carcinoembryonic antigen in a polarized colon carcinoma cell line after cholesterol depletion-Implications for treatment of inflammatory bowel disease. , 2008, World journal of gastroenterology.

[4]  W. Sandborn,et al.  Positioning biologic therapy for Crohn’s disease and ulcerative colitis , 2007, Current gastroenterology reports.

[5]  C. Bode,et al.  Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production , 2007, Critical care medicine.

[6]  T. Giese,et al.  Anti-inflammatory Effects of Phosphatidylcholine* , 2007, Journal of Biological Chemistry.

[7]  R. Xavier,et al.  Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.

[8]  J. Ashton.  Cannabinoids for the treatment of inflammation. , 2007, Current opinion in investigational drugs.

[9]  M. Neurath,et al.  Epithelial NEMO links innate immunity to chronic intestinal inflammation , 2007, Nature.

[10]  P. Mannon,et al.  The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.

[11]  J. Wehkamp,et al.  A New Look at Crohn's Disease , 2006, Annals of the New York Academy of Sciences.

[12]  P. Rutgeerts,et al.  Emerging Biological Treatments in Inflammatory Bowel Diseases , 2006, Digestive Diseases.

[13]  R. McIntyre,et al.  Clathrin heavy chain is required for TNF-induced inflammatory signaling. , 2006, Surgery.

[14]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[15]  I. Ulus,et al.  ENDOTOXIN ALTERS SERUM-FREE CHOLINE AND PHOSPHOLIPID-BOUND CHOLINE CONCENTRATIONS, AND CHOLINE ADMINISTRATION ATTENUATES ENDOTOXIN-INDUCED ORGAN INJURY IN DOGS , 2005, Shock.

[16]  C. Tomasetto,et al.  Give lipids a START: the StAR-related lipid transfer (START) domain in mammals , 2005, Journal of Cell Science.

[17]  F. Autschbach,et al.  Retarded release phosphatidylcholine benefits patients with chronic active ulcerative colitis , 2005, Gut.

[18]  W. Stremmel,et al.  FAT/CD36-mediated long-chain fatty acid uptake in adipocytes requires plasma membrane rafts. , 2004, Molecular biology of the cell.

[19]  S. Nuding,et al.  NF-κB- and AP-1-Mediated Induction of Human Beta Defensin-2 in Intestinal Epithelial Cells by Escherichia coli Nissle 1917: a Novel Effect of a Probiotic Bacterium , 2004, Infection and Immunity.

[20]  C. Penel,et al.  Cytokine-induced upregulation of NF-κB, IL-8, and ICAM-1 is dependent on colonic cell polarity: implication for PKCδ , 2004 .

[21]  W. Lehmann,et al.  Evidence of luminal phosphatidylcholine secretion in rat ileum. , 2004, Biochimica et biophysica acta.

[22]  H. Suh,et al.  Therapeutic effects of lysophosphatidylcholine in experimental sepsis , 2004, Nature Medicine.

[23]  W. Lehmann,et al.  Phosphatidylcholine and lysophosphatidylcholine in intestinal mucus of ulcerative colitis patients. A quantitative approach by nanoelectrospray‐tandem mass spectrometry , 2004, Scandinavian journal of gastroenterology.

[24]  E. Anes,et al.  Selected lipids activate phagosome actin assembly and maturation resulting in killing of pathogenic mycobacteria , 2003, Nature Cell Biology.

[25]  J. Tschopp,et al.  Recruitment of TNF Receptor 1 to Lipid Rafts Is Essential for TNFα-Mediated NF-κB Activation , 2003 .

[26]  G. Schmitz,et al.  Plasma ceramide and lysophosphatidylcholine inversely correlate with mortality in sepsis patients Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200401-JLR200 , 2003, Journal of Lipid Research.

[27]  C. Haass,et al.  Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid rafts , 2003, The Journal of cell biology.

[28]  Kai Simons,et al.  Cholesterol, lipid rafts, and disease. , 2002, The Journal of clinical investigation.

[29]  Mark von Zastrow,et al.  Signal transduction and endocytosis: close encounters of many kinds , 2002, Nature Reviews Molecular Cell Biology.

[30]  D. Riches,et al.  Restricted Localization of the TNF Receptor CD120a to Lipid Rafts: A Novel Role for the Death Domain1 , 2002, The Journal of Immunology.

[31]  N. Tsuji,et al.  Tumor necrosis factor-alpha in serum of patients with inflammatory bowel disease as measured by a highly sensitive immuno-PCR. , 2001, Clinical chemistry.

[32]  J. Medin,et al.  A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling. , 2001, The Biochemical journal.

[33]  J. Hurley,et al.  Floundering about at cell membranes: a structural view of phospholipid signaling. , 2000, Current opinion in structural biology.

[34]  B. Bremnes,et al.  Regulation and Intracellular Trafficking Pathways of the Endothelin Receptors* , 2000, The Journal of Biological Chemistry.

[35]  F. Nervi.  Significance of biliary phospholipids for maintenance of the gastrointestinal mucosal barrier and hepatocellular integrity. , 2000, Gastroenterology.

[36]  M. Kelliher,et al.  The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation. , 2000, Immunity.

[37]  J. M. Kim,et al.  NF-kappa B is a central regulator of the intestinal epithelial cell innate immune response induced by infection with enteroinvasive bacteria. , 1999, Journal of immunology.

[38]  J. Ahn,et al.  TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. , 1999, Journal of immunology.

[39]  M. von Zastrow,et al.  Regulated Endocytosis of G-protein-coupled Receptors by a Biochemically and Functionally Distinct Subpopulation of Clathrin-coated Pits* , 1998, The Journal of Biological Chemistry.

[40]  C. Fiocchi.  Inflammatory bowel disease: etiology and pathogenesis. , 1998, Gastroenterology.

[41]  Stefan Grimm,et al.  The Death Domain Kinase RIP Mediates the TNF-Induced NF-κB Signal , 1998 .

[42]  T. Yoshimura,et al.  Transcriptional Regulation of The Human Monocyte Chemoattractant Protein-1 Gene , 1997, The Journal of Biological Chemistry.

[43]  A. Fauci,et al.  Nuclear factor-kappa B potently up-regulates the promoter activity of RANTES, a chemokine that blocks HIV infection. , 1997, Journal of immunology.

[44]  F. Guarner,et al.  Polyunsaturated phosphatidylcholine prevents stricture formation in a rat model of colitis. , 1996, Gastroenterology.

[45]  Hong-Bing Shu,et al.  TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways , 1996, Cell.

[46]  B. Jeppsson,et al.  Gastrointestinal surface protection and mucosa reconditioning. , 1995, JPEN. Journal of parenteral and enteral nutrition.

[47]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[48]  F. Casellas,et al.  Intraluminal colonic release of immunoreactive tumour necrosis factor in chronic ulcerative colitis. , 1994, Clinical science.

[49]  F. Guarner,et al.  Phosphatidylcholines as mediators of adaptive cytoprotection of the rat duodenum. , 1994, Gastroenterology.

[50]  A. Mantovani,et al.  Chemokines , 1994, The Lancet.

[51]  T. Macdonald,et al.  Location of tumour necrosis factor alpha by immunohistochemistry in chronic inflammatory bowel disease. , 1993, Gut.

[52]  S. Akira,et al.  Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[53]  G. P. Martin,et al.  The Mitigating Effects of Phosphatidylcholines on Bile Salt‐ and Lysophosphatidylcholine‐induced Membrane Damage , 1992, The Journal of pharmacy and pharmacology.

[54]  B. Hills,et al.  Surfactant approach to the gastric mucosal barrier: protection of rats by banana even when acidified. , 1989, Gastroenterology.

[55]  G van Meer,et al.  Lipid sorting in epithelial cells. , 1988, Biochemistry.

[56]  Kevin J. Tracey,et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia , 1987, Nature.

[57]  E. Szigethy,et al.  Inflammatory bowel disease. , 2011, Pediatric clinics of North America.

[58]  J. Kolls,et al.  Chemokines orchestrate leukocyte trafficking in inflammatory bowel disease. , 2008, Frontiers in bioscience : a journal and virtual library.

[59]  G. Lichtenstein.  Phosphatidylcholine for Steroid-Refractory Chronic Ulcerative Colitis: A Randomized Trial , 2008 .

[60]  J. Wehkamp,et al.  A new look at Crohn's disease: breakdown of the mucosal antibacterial defense. , 2006, Annals of the New York Academy of Sciences.

[61]  C. Penel,et al.  Cytokine-induced upregulation of NF-kappaB, IL-8, and ICAM-1 is dependent on colonic cell polarity: implication for PKCdelta. , 2004, Experimental cell research.

[62]  J. Tschopp,et al.  Recruitment of TNF receptor 1 to lipid rafts is essential for TNFalpha-mediated NF-kappaB activation. , 2003, Immunity.

[63]  W. Reenstra,et al.  Synergistic effects of interferon gamma and tumour necrosis factor alpha on T84 cell function. , 1999, Gut.

[64]  P. Leder,et al.  The death domain kinase RIP mediates the TNF-induced NF-kappaB signal. , 1998, Immunity.

[65]  T. Yoshimura,et al.  Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity. , 1997, The Journal of biological chemistry.

[66]  M. Kagnoff,et al.  A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. , 1995, The Journal of clinical investigation.

[67]  L. Lichtenberger.  The hydrophobic barrier properties of gastrointestinal mucus. , 1995, Annual review of physiology.

[68]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. , 1995, Cell.

[69]  S. Bengmark,et al.  Gastroprotective capability of exogenous phosphatidylcholine in experimentally induced chronic gastric ulcers in rats. , 1993, Scandinavian journal of gastroenterology.

[70]  R. Willén,et al.  Effects of phosphatidylcholine and phosphatidylinositol on acetic-acid-induced colitis in the rat. , 1992, Digestion.

[71]  T. Kiviluoto,et al.  Exogenous surface-active phospholipid protects Necturus gastric mucosa against luminal acid and barrier-breaking agents. , 1991, Gastroenterology.

[72]  L. Lichtenberger,et al.  A role for milk phospholipids in protection against gastric acid. Studies in adult and suckling rats. , 1984, Gastroenterology.